ERBB2 and breast cancer: The presence of an axillary lump was significantly related to the BC molecular subtype, with an axillary lump present in the majority of HER2 enriched and Luminal B cases (66.7% and 58.5%, respectively), as well in 42.3% of Luminal A and 39.2% of TNBC cases (p = 0.023).